Bauer H C, Kreicbergs A, Silfverswärd C, Tribukait B
Department of Orthopedic Surgery, Karolinska Institute and Hospital, Stockholm, Sweden.
Anal Quant Cytol Histol. 1989 Apr;11(2):96-103.
In a cytometric DNA study of high-grade osteosarcoma, the relationship between DNA content and morphology was analyzed. The investigation, based on microspectrophotometry of tissue sections and flow cytometry (FCM), included both primary lesions and recurrences. FCM analysis, applied to a consecutive series of 47 primary osteosarcomas, disclosed that 2 were diploid and 45 were nondiploid, 8 of which were tetraploid. Multiple aneuploid peaks were detected in 13 tumors. Among the nondiploid tumors, there was no clear relationship between the peak DNA value(s) and the histologic subtype (osteoblastic, chondroblastic, fibroblastic) or grade (III-IV). The proliferative activity, as reflected by the percentage of S-phase cells, could be determined in 38 of the 47 tumors analyzed by FCM. The percentage was higher for aneuploid than for tetraploid lesions; however, the distribution of S-phase cells was not related to the histologic subtype or the grade of the tumors. To assess the reliability of a single sample for FCM, the DNA content of biopsy and surgical specimens was compared in 20 tumors; there was complete agreement in all cases with respect to the classification of the lesion as diploid, tetraploid or aneuploid. Analysis by FCM or microspectrophotometry of 12 local recurrences and 16 metastases and the corresponding 19 primary tumors showed that an aneuploid characteristic of the primary lesion was retained during progression of the disease. In 12 tumors analyzed by microspectrophotometry in tissue sections, comparison of chondroblastic and osteoblastic/fibroblastic areas within the same lesion consistently disclosed hyperploidy in both areas.(ABSTRACT TRUNCATED AT 250 WORDS)
在一项关于高级别骨肉瘤的细胞DNA研究中,分析了DNA含量与形态之间的关系。该研究基于组织切片的显微分光光度法和流式细胞术(FCM),涵盖了原发性病变和复发病变。对连续47例原发性骨肉瘤进行FCM分析发现,2例为二倍体,45例为非二倍体,其中8例为四倍体。在13个肿瘤中检测到多个非整倍体峰。在非二倍体肿瘤中,峰值DNA值与组织学亚型(成骨细胞型、软骨母细胞型、纤维母细胞型)或分级(III - IV级)之间没有明确关系。通过FCM分析的47个肿瘤中有38个可以确定其增殖活性,以S期细胞百分比表示。非整倍体病变的S期细胞百分比高于四倍体病变;然而,S期细胞的分布与肿瘤的组织学亚型或分级无关。为评估FCM单个样本的可靠性,对20个肿瘤的活检和手术标本的DNA含量进行了比较;在病变分类为二倍体、四倍体或非整倍体的所有情况下,结果完全一致。对12例局部复发、16例转移灶以及相应的19例原发性肿瘤进行FCM或显微分光光度法分析表明,原发性病变的非整倍体特征在疾病进展过程中得以保留。在对12个肿瘤组织切片进行显微分光光度法分析时,同一病变内软骨母细胞区和成骨细胞/纤维母细胞区的比较始终显示两个区域均为超倍体。(摘要截选至250字)